Curation of an international drug proprietary names dataset

Simple item page
dc.contributorUniversiti Sains Malaysia
dc.contributorUniversiti Sains Malaysia
dc.contributorUniversiti Sains Malaysia
dc.contributorUniversiti Sains Malaysia
dc.contributor.authorMohammad A. Khaleel
dc.contributor.authorAmer Hayat Khan
dc.contributor.authorS.M. Sheikh Ghadzi
dc.contributor.authorSami Alshakhshir
dc.date.accessioned2023-05-11T07:00:18Z
dc.date.available2023-05-11T07:00:18Z
dc.date.issued2021-11-22
dc.descriptionWe downloaded the datasets from the official websites of drug authorities or agencies in 44 countries in addition to the European public assessment reports (EPAR) and the DRUGBANK vocabulary. Link to data: https://data.mendeley.com/datasets/9nmgzttxhm/1
dc.description.abstractA drug dataset containing international proprietary names is essential for researchers investigating different drugs from different countries worldwide. However, many websites on the internet offer free access for a single drug searching service to identify international drug trade names, but not for a list of drugs to be searched and identified. Therefore, it will be problematic if the researcher has a list of hundreds or thousands of drug trade names to be identified. In this project, we have created an International Drug Dictionary (IDD) by curating collected drug lists from open access websites belonging to official drug regulatory agencies, official healthcare systems, or recognized scientific bodies from 44 countries around the world in addition to the European public assessment reports (EPAR) and the DRUGBANK vocabulary published in the public domain. Researchers interested in pharmacovigilance, pharmacoepidemiology, or pharmacoeconomics can benefit from this dataset, especially when identifying lists of proprietary drug names, particularly of multi-national origin. To enhance its adaptability, we also mapped the IDD to the standardized drug vocabulary RxNorm. The IDD can also be used as a tool for mapping international drug trade names to RxNorm. Each drug entity in the IDD mapped to a unique identification number for each entity called Atom Unique Identifier (RXAUI) from RxNorm.
dc.identifier.doi10.1016/j.dib.2021.107701
dc.identifier.urihttps://data.mendeley.com/datasets/9nmgzttxhm/1
dc.identifier.urihttps://opendata.usm.my/handle/123456789/74650
dc.publisherElsevier
dc.rightsCC0 1.0 Universal*
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.titleCuration of an international drug proprietary names dataset
dc.typeDataset
Files
Fields
Medical and Health Sciences